Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 15 studies | 55% ± 32% | |
| type II pneumocyte | 12 studies | 52% ± 16% | |
| myofibroblast cell | 6 studies | 32% ± 14% | |
| ciliated cell | 6 studies | 36% ± 10% | |
| Mueller cell | 6 studies | 88% ± 13% | |
| type I pneumocyte | 4 studies | 36% ± 22% | |
| fibroblast | 4 studies | 24% ± 5% | |
| smooth muscle cell | 3 studies | 54% ± 3% | |
| myoepithelial cell | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 4 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 89% | 2937.33 | 517 / 578 | 48% | 48.28 | 558 / 1155 |
| brain | 77% | 3320.34 | 2036 / 2642 | 34% | 9.48 | 241 / 705 |
| prostate | 52% | 339.02 | 127 / 245 | 45% | 6.45 | 225 / 502 |
| breast | 61% | 1017.93 | 282 / 459 | 19% | 13.47 | 207 / 1118 |
| bladder | 29% | 137.33 | 6 / 21 | 14% | 10.68 | 71 / 504 |
| skin | 35% | 204.92 | 634 / 1809 | 6% | 1.91 | 28 / 472 |
| uterus | 11% | 65.28 | 19 / 170 | 20% | 21.84 | 94 / 459 |
| stomach | 12% | 78.95 | 44 / 359 | 18% | 12.28 | 51 / 286 |
| esophagus | 8% | 45.24 | 118 / 1445 | 14% | 3.42 | 26 / 183 |
| eye | 0% | 0 | 0 / 0 | 21% | 13.61 | 17 / 80 |
| intestine | 2% | 8.74 | 18 / 966 | 17% | 6.20 | 88 / 527 |
| adrenal gland | 2% | 8.03 | 4 / 258 | 15% | 20.45 | 34 / 230 |
| ovary | 9% | 121.21 | 17 / 180 | 5% | 2.11 | 20 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 8% | 0.95 | 14 / 178 |
| liver | 0% | 0 | 0 / 226 | 7% | 2.09 | 28 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 4.82 | 3 / 45 |
| adipose | 5% | 46.76 | 62 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 4% | 5.49 | 22 / 605 |
| kidney | 1% | 2.74 | 1 / 89 | 1% | 0.73 | 13 / 901 |
| blood vessel | 1% | 33.34 | 19 / 1335 | 0% | 0 | 0 / 0 |
| heart | 1% | 2.26 | 7 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.45 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0045600 | Biological process | positive regulation of fat cell differentiation |
| GO_0007507 | Biological process | heart development |
| GO_0001568 | Biological process | blood vessel development |
| GO_0007368 | Biological process | determination of left/right symmetry |
| GO_0038092 | Biological process | nodal signaling pathway |
| GO_0009952 | Biological process | anterior/posterior pattern specification |
| GO_0009986 | Cellular component | cell surface |
| GO_0005576 | Cellular component | extracellular region |
| GO_0017147 | Molecular function | Wnt-protein binding |
| GO_0070697 | Molecular function | activin receptor binding |
| GO_0038100 | Molecular function | nodal binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | WIF1 |
| Protein name | Wnt inhibitory factor 1 (WIF-1) WNT inhibitory factor 1 |
| Synonyms | UNQ191/PRO217 |
| Description | FUNCTION: Binds to WNT proteins and inhibits their activities. May be involved in mesoderm segmentation. |
| Accessions | F5H8A3 Q9Y5W5 H0YFK7 ENST00000286574.9 ENST00000543094.1 ENST00000546001.1 |
